The Brisbane facility is designed to support end-to-end RNA programmes, from early R&D to GMP-aligned and clinical-grade production. Key capabilities include:
Dedicated R&D laboratories for construct optimisation and assay development
GMP-compliant production suites with scalable manufacturing
Integrated analytical laboratories for quality control and validation
Controlled documentation and traceability systems
Southern RNA provides plasmid DNA and mRNA services, merging flexible manufacturing with advanced analytics. Our team supports scalable, high-quality nucleic acid production for therapeutic programs.
We provide plasmid DNA (pDNA) and mRNA production using flexible platforms that deliver high-quality R&D and GMP- aligned grade materials at scalable volumes.
We provide a comprehensive nucleic acid analytical platform, supported by the deep expertise and experience of our multidisciplinary scientific team.
Our FAQ section addresses the most common technical and compliance queries, providing clarity on our capabilities, processes, and quality systems.
Yes, our facilities produce GMP-aligned and clinical-grade mRNA and plasmid DNA suitable for early-phase trials.
We follow GMP-aligned processes, robust documentation, and quality oversight to meet regulatory expectations and support submissions.
We offer flexible production from milligram-scale research material to multi-gram clinical-grade batches.
Yes, our in-house analytical team supports identity, purity, impurity profiling, and stability testing across all projects.
Absolutely. Our team develops reproducible processes for smooth transition from research-scale to GMP-aligned clinical production.
